20
Participants
Start Date
April 3, 2024
Primary Completion Date
December 25, 2025
Study Completion Date
June 25, 2026
Chemotherapy and targeted-therapy guided by organoid drug sensitivity test
this study conducts drug sensitivity tests on various clinically approved drugs. The most sensitive drug for the patient is selected for treatment, and the study aims to evaluate the clinical effectiveness of the drug and its consistency with in vitro organoid drug sensitivity.
RECRUITING
Ruijin Hospital Shanghai Jiaotong University School of Medicine, Shanghai
Chongqing Kingbiotech Co.,Ltd
UNKNOWN
Ruijin Hospital
OTHER